8-K Announcements
6Material company update
Feb 26, 2026·SEC
Material company update
Jan 12, 2026·SEC
Material company update
Dec 15, 2025·SEC
Enovis Corporation(ENOV)Earnings, Financials & Key Ratios
ENOV•NYSE
$24.85
$1.42B mkt cap·Price updated May 6, 2026
AboutEnovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.Show more
- Revenue$2.25B+6.7%
- EBITDA-$1.18B-140.7%
- Net Income-$1.18B-43.5%
- EPS (Diluted)-20.86-39.7%
- Gross Margin59.84%+6.8%
- EBITDA Margin-52.57%-125.7%
- Operating Margin-52.57%-42.8%
- Net Margin-52.69%-34.5%
- ROE-58.4%-111.7%
- ROIC-32.41%-118.4%
- Debt/Equity0.06-88.6%
- Interest Coverage-33.93-149.8%
ENOV Key Insights
Enovis Corporation (ENOV) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Company is almost debt free
- ✓Strong 5Y sales CAGR of 14.9%
- ✓Trading at only 0.9x book value
✗Weaknesses
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
ENOV Price & Volume
Enovis Corporation (ENOV) stock price & volume — 10-year historical chart
Loading chart...
ENOV Growth Metrics
Enovis Corporation (ENOV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-5.52%
5 Years14.94%
3 Years12.88%
TTM6.66%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-43.48%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-46.08%
Return on Capital
10 Years-4.27%
5 Years-10.86%
3 Years-17.38%
Last Year-31.83%
ENOV Recent Earnings
Enovis Corporation (ENOV) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 8/12 qtrs (67%)
Q1 2026Latest
Feb 26, 2026EPS
$0.95
Est $0.81
+17.3%
Revenue
$576M
Est $583M
-1.2%
Q4 2025
Nov 6, 2025EPS
$0.75
Est $0.67
+11.9%
Revenue
$549M
Est $584M
-6.1%
Q3 2025
Aug 7, 2025EPS
$0.79
Est $0.74
+6.8%
Revenue
$565M
Est $539M
+4.8%
Q2 2025
May 8, 2025EPS
$0.81
Est $0.74
+9.5%
Revenue
$559M
Est $551M
+1.4%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 26, 2026 | $0.95vs $0.81+17.3% | $576Mvs $583M-1.2% |
| Q4 2025 | Nov 6, 2025 | $0.75vs $0.67+11.9% | $549Mvs $584M-6.1% |
| Q3 2025 | Aug 7, 2025 | $0.79vs $0.74+6.8% | $565Mvs $539M+4.8% |
| Q2 2025 | May 8, 2025 | $0.81vs $0.74+9.5% | $559Mvs $551M+1.4% |
Based on last 12 quarters of dataView full earnings history →
ENOV Peer Comparison
Enovis Corporation (ENOV) competitors in Precision instruments and test equipment — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 10.37% | 0.52 | |
 NVCR | 1.88B | 16.50 | -13.52 | 8.28% | -25.66% | -50.82% | 0.85 | |
 INVA | 1.91B | 22.52 | 6.82 | 18.52% | 118.91% | 46.47% | 0.23 | |
 LMAT | 2.51B | 110.22 | 43.74 | 13.53% | 24.35% | 16.19% | 0.47 | |
 ATRC | 1.42B | 28.01 | -116.71 | 14.88% | -0.83% | -0.95% | 0.18 | |
 ZBH | 16.22B | 82.83 | 23.33 | 7.2% | 9.05% | 5.77% | 0.59 | |
 SNN | 12.84B | 30.26 | 21.01 | 6.34% | 6.88% | 15.06% | 0.63 | |
 GMED | 12.07B | 89.22 | 22.76 | 16.65% | 18.3% | 12.4% | 0.03 |
Compare ENOV vs Peers
Enovis Corporation (ENOV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
ENOV Income Statement
Enovis Corporation (ENOV) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 3.3B | 3.67B | 3.33B | 1.12B | 1.43B | 1.56B | 1.71B | 2.11B | 2.25B |
| Revenue Growth % | -9.51% | 11.11% | -9.25% | -66.32% | 27.26% | 9.6% | 9.22% | 23.46% | 6.66% |
| Cost of Goods Sold | 2.27B | 2.53B | 1.93B | 517.06M | 648.51M | 693.72M | 716.42M | 926.87M | 902.79M |
| COGS % of Revenue | 68.81% | 69.11% | 57.89% | 46.14% | 45.47% | 44.38% | 41.96% | 43.98% | 40.16% |
| Gross Profit | 1.03B▲ 0% | 1.13B▲ 10.0% | 1.4B▲ 23.7% | 603.64M▼ 56.9% | 777.67M▲ 28.8% | 869.38M▲ 11.8% | 990.78M▲ 14.0% | 1.18B▲ 19.2% | 1.35B▲ 13.9% |
| Gross Margin % | 31.19% | 30.89% | 42.11% | 53.86% | 54.53% | 55.62% | 58.04% | 56.02% | 59.84% |
| Gross Profit Growth % | -10.14% | 10.04% | 23.68% | -56.92% | 28.83% | 11.79% | 13.96% | 19.17% | 13.93% |
| Operating Expenses | 732.34M | 818.21M | 1.2B | 669.82M | 840.47M | 940.56M | 1.06B | 1.96B | 1.19B |
| OpEx % of Revenue | 22.19% | 22.31% | 35.99% | 59.77% | 58.93% | 60.17% | 61.88% | 92.83% | 52.96% |
| Selling, General & Admin | 732.34M | 818.21M | 1.13B | 515.47M | 665.77M | 772.91M | 830.3M | 939.36M | 1.07B |
| SG&A % of Revenue | 22.19% | 22.31% | 34.02% | 46% | 46.68% | 49.45% | 48.64% | 44.57% | 47.6% |
| Research & Development | 42.9M | 34.2M | 0 | 34.27M | 49.09M | 60.83M | 75.33M | 91.3M | 120.33M |
| R&D % of Revenue | 1.3% | 0.93% | - | 3.06% | 3.44% | 3.89% | 4.41% | 4.33% | 5.35% |
| Other Operating Expenses | -46.93M | 39K | 65.3M | 120.09M | 125.61M | 106.82M | 150.85M | 925.81M | 0 |
| Operating Income | 29.15M▲ 0% | 236.94M▲ 712.8% | 203.61M▼ 14.1% | -66.18M▼ 132.5% | -62.8M▲ 5.1% | -71.18M▼ 13.3% | -65.71M▲ 7.7% | -775.72M▼ 1080.5% | -1.18B▼ 52.3% |
| Operating Margin % | 0.88% | 6.46% | 6.12% | -5.91% | -4.4% | -4.55% | -3.85% | -36.81% | -52.57% |
| Operating Income Growth % | -87.75% | 712.81% | -14.07% | -132.5% | 5.11% | -13.34% | 7.68% | -1080.54% | -52.34% |
| EBITDA | 152.57M | 378.82M | 439.64M | 180.05M | 200.12M | 148.53M | 151.4M | -490.92M | -1.18B |
| EBITDA Margin % | 4.62% | 10.33% | 13.21% | 16.07% | 14.03% | 9.5% | 8.87% | -23.29% | -52.57% |
| EBITDA Growth % | -56.14% | 148.29% | 16.05% | -59.05% | 11.15% | -25.78% | 1.93% | -424.26% | -140.71% |
| D&A (Non-Cash Add-back) | 123.42M | 141.88M | 236.03M | 246.23M | 262.92M | 219.71M | 217.11M | 284.8M | 0 |
| EBIT | 36.99M | 141.45M | 170M | -66.18M | -92.67M | 21.98M | -47.38M | -765.82M | 0 |
| Net Interest Income | -40.11M | -49.08M | -119.5M | -52.82M | -29.11M | -24.75M | -19.75M | -57.1M | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 200K | 0 | 0 | 0 |
| Interest Expense | 40.11M | 49.08M | 119.5M | 52.82M | 29.11M | 24.95M | 19.75M | 57.1M | 34.82M |
| Other Income/Expense | -147.58M | -59.17M | -153.12M | -52.82M | -58.98M | 69.11M | -1.42M | -47.2M | 22.29M |
| Pretax Income | -11.99M▲ 0% | 182.8M▲ 1625.1% | 50.49M▼ 72.4% | -119.01M▼ 335.7% | -121.78M▼ 2.3% | -2.07M▲ 98.3% | -67.13M▼ 3144.5% | -822.92M▼ 1125.9% | -1.16B▼ 40.9% |
| Pretax Margin % | -0.36% | 4.99% | 1.52% | -10.62% | -8.54% | -0.13% | -3.93% | -39.05% | -51.57% |
| Income Tax | 42.55M | -21K | 31.63M | -44.58M | -19.53M | 36.12M | -13.29M | 4.49M | 22.29M |
| Effective Tax Rate % | -355.03% | -0.01% | 62.64% | 37.46% | 16.04% | -1745.77% | 19.8% | -0.55% | -1.92% |
| Net Income | 151.09M▲ 0% | 140.2M▼ 7.2% | -527.65M▼ 476.4% | 42.63M▲ 108.1% | 71.66M▲ 68.1% | -13.29M▼ 118.5% | -33.26M▼ 150.2% | -825.49M▼ 2381.9% | -1.18B▼ 43.5% |
| Net Margin % | 4.58% | 3.82% | -15.86% | 3.8% | 5.02% | -0.85% | -1.95% | -39.17% | -52.69% |
| Net Income Growth % | 17.94% | -7.21% | -476.36% | 108.08% | 68.11% | -118.55% | -150.23% | -2381.87% | -43.48% |
| Net Income (Continuing) | 46.08M | 121.87M | 18.86M | -74.43M | -102.25M | -38.19M | -53.84M | -827.42M | -1.18B |
| Discontinued Operations | 123.43M | 32.6M | -536.01M | 120.2M | 178.53M | 26.43M | 21.11M | 2.6M | 0 |
| Minority Interest | 226.85M | 207.19M | 48.2M | 44.49M | 44.05M | 1.72M | 2.31M | 2.07M | 2.26M |
| EPS (Diluted) | 3.66▲ 0% | 3.48▼ 4.9% | 0.41▼ 88.2% | 1.11▲ 170.7% | -2.02▼ 282.0% | -0.28▲ 86.1% | -0.61▼ 117.9% | -14.93▼ 2347.5% | -20.86▼ 39.7% |
| EPS Growth % | 17.31% | -4.92% | -88.22% | 170.73% | -281.98% | 86.14% | -117.86% | -2347.54% | -39.72% |
| EPS (Basic) | 3.69 | 3.50 | 0.42 | 1.13 | -2.02 | -0.28 | -0.61 | -14.93 | -20.86 |
| Diluted Shares Outstanding | 41.33M | 40.29M | 45.56M | 46.3M | 51.14M | 54.07M | 54.49M | 55.28M | 56.79M |
| Basic Shares Outstanding | 40.95M | 40.1M | 45.24M | 45.59M | 51.14M | 54.07M | 54.53M | 55.28M | 56.79M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
ENOV Balance Sheet
Enovis Corporation (ENOV) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 2.07B | 1.96B | 1.4B | 1.36B | 2.3B | 795.02M | 896.52M | 1.15B | 1.21B |
| Cash & Short-Term Investments | 411.63M | 245.02M | 109.63M | 101.07M | 680.25M | 24.3M | 36.19M | 48.17M | 36.39M |
| Cash Only | 262.02M | 245.02M | 109.63M | 101.07M | 680.25M | 24.3M | 36.19M | 48.17M | 36.39M |
| Short-Term Investments | 149.61M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 970.2M | 386.59M | 561.87M | 517.01M | 254.96M | 267.38M | 291.48M | 407.03M | 0 |
| Days Sales Outstanding | 107.3 | 38.48 | 61.63 | 168.38 | 65.25 | 62.44 | 62.32 | 70.49 | - |
| Inventory | 429.63M | 496.54M | 571.56M | 564.82M | 356.23M | 426.64M | 468.83M | 547.12M | 584.38M |
| Days Inventory Outstanding | 69.06 | 71.52 | 108.29 | 398.72 | 200.5 | 224.48 | 238.86 | 215.46 | 236.27 |
| Other Current Assets | 258.38M | 1.14B | 90.76M | 113.42M | 985.79M | 48.16M | 71.11M | 107.88M | 586.29M |
| Total Non-Current Assets | 4.65B | 4.65B | 5.98B | 5.99B | 6.21B | 3.48B | 3.61B | 3.57B | 2.63B |
| Property, Plant & Equipment | 552.8M | 503.34M | 664.56M | 660.9M | 311.6M | 303.62M | 334.3M | 473.42M | 579.32M |
| Fixed Asset Turnover | 5.97x | 7.28x | 5.01x | 1.70x | 4.58x | 5.15x | 5.11x | 4.45x | 3.88x |
| Goodwill | 2.54B | 2.58B | 3.2B | 3.31B | 1.93B | 1.98B | 2.06B | 1.69B | 718.3M |
| Intangible Assets | 1.02B | 1.01B | 1.72B | 1.66B | 1.15B | 1.11B | 1.13B | 1.32B | 1.24B |
| Long-Term Investments | 73.49M | 62.52M | 41.63M | 31.82M | 15.42M | 16.5M | 0 | 20.4M | 0 |
| Other Non-Current Assets | 543.27M | 552.56M | 396.49M | 350.83M | 2.8B | 80.29M | 90.25M | 68.38M | 93.35M |
| Total Assets | 6.72B▲ 0% | 6.6B▼ 1.8% | 7.39B▲ 11.9% | 7.35B▼ 0.5% | 8.52B▲ 15.8% | 4.27B▼ 49.8% | 4.51B▲ 5.5% | 4.72B▲ 4.6% | 3.83B▼ 18.7% |
| Asset Turnover | 0.49x | 0.56x | 0.45x | 0.15x | 0.17x | 0.37x | 0.38x | 0.45x | 0.59x |
| Asset Growth % | 5.26% | -1.75% | 11.86% | -0.48% | 15.84% | -49.82% | 5.52% | 4.64% | -18.73% |
| Total Current Liabilities | 1.1B | 1.2B | 857.31M | 811.66M | 1.02B | 565.2M | 369.61M | 529M | 598.47M |
| Accounts Payable | 587.13M | 291.23M | 359.78M | 330.25M | 155.21M | 135.63M | 132.47M | 179.1M | 187.53M |
| Days Payables Outstanding | 94.38 | 41.95 | 68.17 | 233.13 | 87.36 | 71.36 | 67.49 | 70.53 | 75.82 |
| Short-Term Debt | 5.77M | 5.02M | 67.66M | 66.77M | 29.64M | 243.56M | 21.57M | 20.03M | 35M |
| Deferred Revenue (Current) | 145.85M | 16.83M | 16.01M | 36.74M | 9.2M | 3.56M | 2.95M | 6.23M | 0 |
| Other Current Liabilities | 206.56M | 758.5M | 258.31M | 222.16M | 736.57M | 101.72M | 114.21M | 188.97M | 563.47M |
| Current Ratio | 1.89x | 1.63x | 1.64x | 1.68x | 2.25x | 1.41x | 2.43x | 2.17x | 2.02x |
| Quick Ratio | 1.49x | 1.22x | 0.97x | 0.98x | 1.90x | 0.65x | 1.16x | 1.13x | 1.04x |
| Cash Conversion Cycle | 81.99 | 68.05 | 101.76 | 333.97 | 178.39 | 215.55 | 233.69 | 215.42 | - |
| Total Non-Current Liabilities | 1.9B | 1.93B | 3.04B | 2.95B | 2.83B | 258.25M | 719.03M | 1.63B | 1.74B |
| Long-Term Debt | 1.06B | 1.19B | 2.28B | 2.2B | 2.08B | 40M | 466.16M | 1.31B | 58M |
| Capital Lease Obligations | 0 | 0 | 136.4M | 139.23M | 56.55M | 51.26M | 48.68M | 52.46M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 829.75M | 747.26M | 619.31M | 608.62M | 695.72M | 166.99M | 204.18M | 263.52M | 1.69B |
| Total Liabilities | 2.99B | 3.13B | 3.9B | 3.76B | 3.85B | 823.45M | 1.09B | 2.15B | 2.34B |
| Total Debt | 1.06B | 1.2B | 2.49B | 2.41B | 2.16B | 334.82M | 536.42M | 1.4B | 93M |
| Net Debt | 799.05M | 1.12B | 2.38B | 2.31B | 1.48B | 310.52M | 500.23M | 1.36B | 56.61M |
| Debt / Equity | 0.28x | 0.34x | 0.71x | 0.67x | 0.46x | 0.10x | 0.16x | 0.55x | 0.06x |
| Debt / EBITDA | 6.95x | 3.16x | 5.66x | 13.39x | 10.82x | 2.25x | 3.54x | - | - |
| Net Debt / EBITDA | 5.24x | 2.96x | 5.41x | 12.82x | 7.42x | 2.09x | 3.30x | - | - |
| Interest Coverage | 0.73x | 4.83x | 1.70x | -1.25x | -2.16x | -2.85x | -3.33x | -13.59x | -33.93x |
| Total Equity | 3.73B▲ 0% | 3.48B▼ 6.7% | 3.49B▲ 0.4% | 3.59B▲ 2.8% | 4.66B▲ 29.9% | 3.45B▼ 26.0% | 3.42B▼ 0.8% | 2.56B▼ 25.0% | 1.49B▼ 41.8% |
| Equity Growth % | 20.49% | -6.72% | 0.36% | 2.82% | 29.92% | -25.99% | -0.84% | -25.04% | -41.82% |
| Book Value per Share | 90.18 | 86.31 | 76.60 | 77.49 | 91.15 | 63.81 | 62.77 | 46.39 | 26.27 |
| Total Shareholders' Equity | 3.5B | 3.27B | 3.44B | 3.54B | 4.62B | 3.45B | 3.42B | 2.56B | 1.49B |
| Common Stock | 123K | 117K | 118K | 118K | 52K | 54K | 55K | 56K | 57K |
| Retained Earnings | 846.49M | 991.84M | 479.56M | 517.37M | 589.02M | 575.73M | 542.47M | -283.02M | -1.47B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -574.37M | -780.18M | -483.85M | -452.11M | -516.01M | -53.43M | -24.88M | -127.89M | -91.36M |
| Minority Interest | 226.85M | 207.19M | 48.2M | 44.49M | 44.05M | 1.72M | 2.31M | 2.07M | 2.26M |
ENOV Cash Flow Statement
Enovis Corporation (ENOV) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 218.77M | 226.37M | 130.95M | 301.94M | 356.1M | -55.86M | 134.99M | 113.5M | 217.29M |
| Operating CF Margin % | 6.63% | 6.17% | 3.94% | 26.94% | 24.97% | -3.57% | 7.91% | 5.39% | 9.67% |
| Operating CF Growth % | -11.42% | 3.47% | -42.15% | 130.58% | 17.94% | -115.69% | 341.65% | -15.92% | 91.44% |
| Net Income | 169.51M | 154.47M | -517.15M | 45.77M | 76.28M | -11.76M | -33.26M | -824.82M | -1.18B |
| Depreciation & Amortization | 134.75M | 141.88M | 236.03M | 246.23M | 262.92M | 219.71M | 217.1M | 284.8M | 294.38M |
| Stock-Based Compensation | 21.55M | 25.1M | 21.96M | 28.91M | 35.35M | 38.95M | 34.06M | 29.66M | 32.92M |
| Deferred Taxes | 12.07M | -66.57M | -590K | -29.22M | -22.19M | 6.32M | -27.41M | -10.02M | -2.23M |
| Other Non-Cash Items | -86.98M | 4.82M | 522.15M | 5.25M | 20.84M | -88.59M | -28.24M | 647.81M | 1.08B |
| Working Capital Changes | -32.13M | -33.33M | -131.46M | 4.99M | -17.1M | -220.49M | -27.27M | -13.93M | 0 |
| Change in Receivables | -44.34M | -72.41M | 49.92M | 42.69M | -110.98M | -45.19M | -16.32M | -57.05M | -10.75M |
| Change in Inventory | -34.02M | -47.16M | -44.89M | 23.79M | -129.97M | -118.79M | -24.74M | 39.07M | -11.98M |
| Change in Payables | 10.27M | 70.08M | -119.33M | -30.75M | 178.47M | -11.84M | -6.64M | 13.98M | -1.14M |
| Cash from Investing | 89.88M | -167.85M | -1.63B | -175.08M | -320.48M | -176.39M | -242.47M | -955.47M | -179.37M |
| Capital Expenditures | -68.77M | -69.65M | -125.4M | -114.78M | -104.24M | -105.45M | -122.22M | -180.71M | -197.38M |
| CapEx % of Revenue | 2.08% | 1.9% | 3.77% | 10.24% | 7.31% | 6.75% | 7.16% | 8.57% | 8.78% |
| Acquisitions | 143.54M | -272.51M | -1.52B | -69.85M | -223.27M | -73.68M | -152.81M | -769.91M | 0 |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 15.1M | 34.83M | 7.78M | 9.55M | 7.03M | 2.75M | 32.57M | -4.84M | 18M |
| Cash from Financing | -280.45M | -47.15M | 1.37B | -131.65M | 584.91M | -465.13M | 127.8M | 846.82M | -52.4M |
| Debt Issued (Net) | -277.38M | 158.24M | 1.11B | -118.32M | -150.41M | -1.59B | 217.19M | 859.23M | 0 |
| Equity Issued (Net) | 1000K | -1000K | 1000K | 1000K | 1000K | 1000K | 1000K | -1000K | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | -200M | 0 | 0 | 0 | 0 | 0 | -4.77M | 0 |
| Other Financing | -10.01M | -5.39M | 248.83M | -16.84M | -9.87M | 1.12B | -91.17M | -9.51M | -52.4M |
| Net Change in Cash | 40.29M▲ 0% | -17M▼ 142.2% | -135.39M▼ 696.4% | -8.56M▲ 93.7% | 618.3M▲ 7320.6% | -695.08M▼ 212.4% | 20.54M▲ 103.0% | 3.33M▼ 83.8% | -11.78M▼ 453.2% |
| Free Cash Flow | 150M▲ 0% | 156.72M▲ 4.5% | 5.55M▼ 96.5% | 187.15M▲ 3274.5% | 251.86M▲ 34.6% | -161.31M▼ 164.0% | 12.77M▲ 107.9% | -67.21M▼ 626.5% | 19.92M▲ 129.6% |
| FCF Margin % | 4.55% | 4.27% | 0.17% | 16.7% | 17.66% | -10.32% | 0.75% | -3.19% | 0.89% |
| FCF Growth % | -18.35% | 4.48% | -96.46% | 3274.5% | 34.58% | -164.05% | 107.91% | -626.52% | 129.63% |
| FCF per Share | 3.63 | 3.89 | 0.12 | 4.04 | 4.92 | -2.98 | 0.23 | -1.22 | 0.35 |
| FCF Conversion (FCF/Net Income) | 1.45x | 1.61x | -0.25x | 7.08x | 4.97x | 4.20x | -4.06x | -0.14x | -0.18x |
| Interest Paid | 43.5M | 50.39M | 139.27M | 104.62M | 85.49M | 37.09M | 16.33M | 51.83M | 0 |
| Taxes Paid | 70.67M | 97.45M | 134.91M | 59.38M | 47.19M | 31.36M | 12.52M | 10.8M | 0 |
ENOV Key Ratios
Enovis Corporation (ENOV) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.04% | 4.43% | 3.89% | -15.15% | 1.2% | 1.74% | -0.33% | -0.97% | -27.59% | -58.4% |
| Return on Invested Capital (ROIC) | 4.13% | 0.5% | 3.97% | 2.97% | -0.84% | -0.78% | -1.08% | -1.28% | -14.84% | -32.41% |
| Gross Margin | 31.41% | 31.19% | 30.89% | 42.11% | 53.86% | 54.53% | 55.62% | 58.04% | 56.02% | 59.84% |
| Net Margin | 3.51% | 4.58% | 3.82% | -15.86% | 3.8% | 5.02% | -0.85% | -1.95% | -39.17% | -52.69% |
| Debt / Equity | 0.42x | 0.28x | 0.34x | 0.71x | 0.67x | 0.46x | 0.10x | 0.16x | 0.55x | 0.06x |
| Interest Coverage | 7.93x | 0.73x | 4.83x | 1.70x | -1.25x | -2.16x | -2.85x | -3.33x | -13.59x | -33.93x |
| FCF Conversion | 1.93x | 1.45x | 1.61x | -0.25x | 7.08x | 4.97x | 4.20x | -4.06x | -0.14x | -0.18x |
| Revenue Growth | -8.07% | -9.51% | 11.11% | -9.25% | -66.32% | 27.26% | 9.6% | 9.22% | 23.46% | 6.66% |
ENOV SEC Filings & Documents
Enovis Corporation (ENOV) SEC filings — annual & quarterly reports (10-K, 10-Q)
ENOV Frequently Asked Questions
Enovis Corporation (ENOV) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Enovis Corporation (ENOV) reported $2.25B in revenue for fiscal year 2025. This represents a 551% increase from $345.5M in 2005.
Enovis Corporation (ENOV) grew revenue by 6.7% over the past year. This is steady growth.
Enovis Corporation (ENOV) reported a net loss of $1.18B for fiscal year 2025.
Dividend & Returns
Enovis Corporation (ENOV) has a return on equity (ROE) of -58.4%. Negative ROE indicates the company is unprofitable.
Enovis Corporation (ENOV) had negative free cash flow of $84.2M in fiscal year 2025, likely due to heavy capital investments.
Explore More ENOV
Enovis Corporation (ENOV) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates